BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36211427)

  • 1. Process development and preclinical evaluation of a major
    Somanathan A; Mian SY; Chaddha K; Uchoi S; Bharti PK; Tandon R; Gaur D; Chauhan VS
    Front Immunol; 2022; 13():1005332. PubMed ID: 36211427
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
    Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
    Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
    Healer J; Thompson JK; Mackwell KL; Browne CD; Seager BA; Ngo A; Lowes KN; Silk SE; Pulido D; King LDW; Christen JM; Noe AR; Kotraiah V; Masendycz PJ; Rajagopalan R; Lucas L; Stanford MM; Soisson L; Diggs C; Miller R; Youll S; Wycherley K; Draper SJ; Cowman AF
    Front Cell Infect Microbiol; 2022; 12():1049065. PubMed ID: 36605129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
    Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
    J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
    Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
    Singh H; Mian SY; Pandey AK; Krishna S; Anand G; Reddy KS; Chaturvedi N; Bahl V; Hans N; Shukla MM; Bassat Q; Mayor A; Miura K; Bharti PK; Long C; Singh N; Chauhan VS; Gaur D
    J Infect Dis; 2021 Jun; 223(11):1953-1964. PubMed ID: 32989463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
    Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
    Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
    Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
    Front Immunol; 2021; 12():716305. PubMed ID: 34447381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site.
    Campeotto I; Galaway F; Mehmood S; Barfod LK; Quinkert D; Kotraiah V; Phares TW; Wright KE; Snijders AP; Draper SJ; Higgins MK; Wright GJ
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900802
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
    Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
    Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
    Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
    Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
    Ragotte RJ; Higgins MK; Draper SJ
    Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Immune Assessment of T Cell Epitopes in Five
    Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
    Front Immunol; 2021; 12():690348. PubMed ID: 34305923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
    Wong W; Huang R; Menant S; Hong C; Sandow JJ; Birkinshaw RW; Healer J; Hodder AN; Kanjee U; Tonkin CJ; Heckmann D; Soroka V; Søgaard TMM; Jørgensen T; Duraisingh MT; Czabotar PE; de Jongh WA; Tham WH; Webb AI; Yu Z; Cowman AF
    Nature; 2019 Jan; 565(7737):118-121. PubMed ID: 30542156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.